Skip to main content
Top
Published in: Sports Medicine 12/2009

01-12-2009 | Research Review

Oligomenorrhoea in Exercising Women

A Polycystic Ovarian Syndrome Phenotype or Distinct Entity?

Authors: Susan Awdishu, Nancy I. Williams, Sheila E. Laredo, Mary Jane De Souza

Published in: Sports Medicine | Issue 12/2009

Login to get access

Abstract

To date, the predominant mechanism underlying menstrual disturbances in exercising women supports an underlying energy deficiency-related aetiology, in which a failure to compensate dietary intake for the energy cost of exercise suppresses reproductive function. Increasing evidence demonstrates that energy deficiency plays a causal role in the induction of amenorrhoea in exercising women, and consistent with this mechanism are findings of glucoregulatory perturbations such as low triiodothyronine, reduced insulin secretion and elevated cortisol, growth hormone and ghrelin levels. The menstrual disturbance that may differ in its energetic characteristics and, perhaps in its androgenic and ovarian steroid environment, is oligomenorrhoea. We conducted a systematic review of the literature to begin to understand whether oligomenorrhoea in exercising women is a mild subclinical phenotype of polycystic ovarian syndrome (PCOS) in which exercise is conferring beneficial effects in protecting women from the classic PCOS phenotype, or whether oligomenorrhoea is part of the spectrum of menstrual disturbances caused by an energy deficiency that is often reported in exercising women with menstrual disturbances. We included observational, randomized controlled trials and cross-sectional studies that reported clinical, hormonal and metabolic profiles in exercising women with amenorrhoea or oligomenorrhoea and in women with PCOS. Previous studies examining the underlying mechanisms and consequences of exercise-associated menstrual disturbances have grouped exercising amenorrhoeic and oligomenorrhoeic women into a single group, and have relied primarily on self-reported menstrual history. Although scarce, the data available to date suggest that hyperandrogenism, such as that observed in PCOS, may likely be associated with oligomenorrhoea in exercising women, and may not always represent hypothalamic inhibition secondary to an energy deficiency. It is critical to closely examine the metabolic and endocrine status of women with menstrual disturbances because the treatment strategies for energy deficiency-related menstrual disturbances differ from that of disturbances traceable to hyperandrogenaemia. Further investigation is necessary to explore whether different endocrine aetiologies underly menstrual disturbances, particularly oligomenorrhoea, in physically active women.
Literature
2.
go back to reference Knobil E. The wisdom of the body revisited. News Physiol Sci 1999; 14 (2): 1–11PubMed Knobil E. The wisdom of the body revisited. News Physiol Sci 1999; 14 (2): 1–11PubMed
4.
go back to reference De Souza MJ, Williams NI. Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum Reprod Update 2004; 10 (5): 433–48CrossRefPubMed De Souza MJ, Williams NI. Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum Reprod Update 2004; 10 (5): 433–48CrossRefPubMed
5.
go back to reference De Souza MJ, Miller BE, Loucks AB, et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab 1998; 83 (12): 4220–32PubMed De Souza MJ, Miller BE, Loucks AB, et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab 1998; 83 (12): 4220–32PubMed
6.
go back to reference Sanborn CF, Martin BJ, Wagner Jr WW. Is athletic amenorrhea specific to runners? Am J Obstet Gynecol 1982; 143 (8): 859–61CrossRefPubMed Sanborn CF, Martin BJ, Wagner Jr WW. Is athletic amenorrhea specific to runners? Am J Obstet Gynecol 1982; 143 (8): 859–61CrossRefPubMed
7.
go back to reference Constantini NW, Warren MP. Menstrual dysfunction in swimmers: a distinct entity. J Clin Endocrinol Metab 1995; 80 (9): 2740–4PubMed Constantini NW, Warren MP. Menstrual dysfunction in swimmers: a distinct entity. J Clin Endocrinol Metab 1995; 80 (9): 2740–4PubMed
8.
go back to reference Feicht CB, Johnson TS, Martin BJ, et al. Secondary amenorrhoea in athletes. Lancet 1978; 2 (8100): 1145–6CrossRefPubMed Feicht CB, Johnson TS, Martin BJ, et al. Secondary amenorrhoea in athletes. Lancet 1978; 2 (8100): 1145–6CrossRefPubMed
9.
go back to reference Dale E, Gerlach DH, Wilhite AL. Menstrual dysfunction in distance runners. Obstet Gynecol 1979; 54 (1): 47–53CrossRefPubMed Dale E, Gerlach DH, Wilhite AL. Menstrual dysfunction in distance runners. Obstet Gynecol 1979; 54 (1): 47–53CrossRefPubMed
10.
go back to reference Schwartz B, Cumming DC, Riordan E, et al. Exerciseassociated amenorrhea: a distinct entity? Am J Obstet Gynecol 1981; 141 (6): 662–70CrossRefPubMed Schwartz B, Cumming DC, Riordan E, et al. Exerciseassociated amenorrhea: a distinct entity? Am J Obstet Gynecol 1981; 141 (6): 662–70CrossRefPubMed
11.
12.
go back to reference Loucks AB, Verdun M, Heath EM. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 1998; 84 (1): 37–46CrossRefPubMed Loucks AB, Verdun M, Heath EM. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 1998; 84 (1): 37–46CrossRefPubMed
13.
go back to reference Williams NI, Caston-Balderrama AL, Helmreich DL, et al. Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology 2001; 142 (6): 2381–9CrossRefPubMed Williams NI, Caston-Balderrama AL, Helmreich DL, et al. Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology 2001; 142 (6): 2381–9CrossRefPubMed
14.
go back to reference Williams NI, Helmreich DL, Parfitt DB, et al. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 2001; 86 (11): 5184–93CrossRefPubMed Williams NI, Helmreich DL, Parfitt DB, et al. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 2001; 86 (11): 5184–93CrossRefPubMed
15.
go back to reference De Souza MJ, Lee DK, VanHeest JL, et al. Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril 2007; 88 (4): 971–5CrossRefPubMed De Souza MJ, Lee DK, VanHeest JL, et al. Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril 2007; 88 (4): 971–5CrossRefPubMed
16.
go back to reference De Souza MJ, Leidy HJ, O’Donnell E, et al. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004; 89 (7): 3536–42CrossRefPubMed De Souza MJ, Leidy HJ, O’Donnell E, et al. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004; 89 (7): 3536–42CrossRefPubMed
17.
go back to reference Laughlin GA, Yen SS. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab 1996; 81 (12): 4301–9PubMed Laughlin GA, Yen SS. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab 1996; 81 (12): 4301–9PubMed
18.
go back to reference Wade GN, Schneider JE, Li HY. Control of fertility by metabolic cues. Am J Physiol 1996; 270 (1 Pt 1): E1–19 Wade GN, Schneider JE, Li HY. Control of fertility by metabolic cues. Am J Physiol 1996; 270 (1 Pt 1): E1–19
19.
go back to reference Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004; 351 (10): 987–97CrossRefPubMed Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004; 351 (10): 987–97CrossRefPubMed
20.
go back to reference Loucks AB, Laughlin GA, Mortola JF, et al. Hypothalamic- pituitary-thyroidal function in eumenorrheic and amenorrheic athletes. J Clin Endocrinol Metab 1992; 75 (2): 514–8PubMed Loucks AB, Laughlin GA, Mortola JF, et al. Hypothalamic- pituitary-thyroidal function in eumenorrheic and amenorrheic athletes. J Clin Endocrinol Metab 1992; 75 (2): 514–8PubMed
21.
go back to reference Laughlin GA, Yen SSC. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997; 82 (1): 318–21CrossRefPubMed Laughlin GA, Yen SSC. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997; 82 (1): 318–21CrossRefPubMed
22.
go back to reference De Souza MJ, Van Heest J, Demers LM, et al. Luteal phase deficiency in recreational runners: evidence for a hypometabolic state. J Clin Endocrinol Metab 2003; 88 (1): 337–46CrossRefPubMed De Souza MJ, Van Heest J, Demers LM, et al. Luteal phase deficiency in recreational runners: evidence for a hypometabolic state. J Clin Endocrinol Metab 2003; 88 (1): 337–46CrossRefPubMed
23.
go back to reference Rickenlund A, CarlstrÖm K, Ekblom B, et al. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance. Fertil Steril 2003; 79 (4): 947–55CrossRefPubMed Rickenlund A, CarlstrÖm K, Ekblom B, et al. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance. Fertil Steril 2003; 79 (4): 947–55CrossRefPubMed
24.
go back to reference Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91 (11): 4237–45CrossRefPubMed Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91 (11): 4237–45CrossRefPubMed
25.
go back to reference Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, et al., editors. Polycystic ovary syndrome. Boston (MA): Blackwell Scientific, 1992: 377–84 Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, et al., editors. Polycystic ovary syndrome. Boston (MA): Blackwell Scientific, 1992: 377–84
26.
go back to reference Azziz R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89 (6): 2745–9CrossRefPubMed Azziz R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89 (6): 2745–9CrossRefPubMed
27.
go back to reference Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84 (11): 4006–11CrossRefPubMed Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84 (11): 4006–11CrossRefPubMed
28.
go back to reference Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19 (1): 41–7 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19 (1): 41–7
29.
go back to reference Zanker CL, Swaine IL. The relationship between serum oestradiol concentration and energy balance in young women distance runners. Int J Sports Med 1998; 19 (2): 104–8CrossRefPubMed Zanker CL, Swaine IL. The relationship between serum oestradiol concentration and energy balance in young women distance runners. Int J Sports Med 1998; 19 (2): 104–8CrossRefPubMed
30.
go back to reference Orio F, Vuolo L, Palomba S, et al. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf) 2008; 68 (6): 976–81CrossRef Orio F, Vuolo L, Palomba S, et al. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf) 2008; 68 (6): 976–81CrossRef
31.
go back to reference Loucks AB, Mortola JF, Girton L, et al. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamicpituitary- adrenal axes in athletic women. J Clin Endocrinol Metab 1989; 68 (2): 402–11CrossRefPubMed Loucks AB, Mortola JF, Girton L, et al. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamicpituitary- adrenal axes in athletic women. J Clin Endocrinol Metab 1989; 68 (2): 402–11CrossRefPubMed
32.
go back to reference Carlberg KA, Buckman MT, Peake GT, et al. Body composition of oligo/amenorrheic athletes. Med Sci Sports Exerc 1983; 15 (3): 215–7CrossRefPubMed Carlberg KA, Buckman MT, Peake GT, et al. Body composition of oligo/amenorrheic athletes. Med Sci Sports Exerc 1983; 15 (3): 215–7CrossRefPubMed
33.
go back to reference Cobb KL, Bachrach LK, Greendale G, et al. Disordered eating, menstrual irregularity, and bone mineral density in female runners. Med Sci Sports Exerc 2003; 35 (5): 711–9CrossRefPubMed Cobb KL, Bachrach LK, Greendale G, et al. Disordered eating, menstrual irregularity, and bone mineral density in female runners. Med Sci Sports Exerc 2003; 35 (5): 711–9CrossRefPubMed
34.
go back to reference Shangold MM. Causes, evaluation, and management of athletic oligo/amenorrhea. Med Clin North Am 1985; 69 (1): 83–95CrossRefPubMed Shangold MM. Causes, evaluation, and management of athletic oligo/amenorrhea. Med Clin North Am 1985; 69 (1): 83–95CrossRefPubMed
35.
go back to reference Wakat DK, Sweeney KA, Rogol AD. Reproductive system function in women cross-country runners. Med Sci Sports Exerc 1982; 14 (4): 263–9CrossRefPubMed Wakat DK, Sweeney KA, Rogol AD. Reproductive system function in women cross-country runners. Med Sci Sports Exerc 1982; 14 (4): 263–9CrossRefPubMed
36.
go back to reference Rickenlund A, Thorén M, Carlström K, et al. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab 2004; 89 (2): 702–7CrossRefPubMed Rickenlund A, Thorén M, Carlström K, et al. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab 2004; 89 (2): 702–7CrossRefPubMed
37.
go back to reference De Souza MJ, Lee D, Van Heest JL, et al. Severity of energyrelated menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril 2007; 88 (4): 971–5CrossRefPubMed De Souza MJ, Lee D, Van Heest JL, et al. Severity of energyrelated menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril 2007; 88 (4): 971–5CrossRefPubMed
38.
39.
go back to reference Taponen S, Martikainen H, Järvelin MR, et al. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab 2003; 88 (1): 141–7CrossRefPubMed Taponen S, Martikainen H, Järvelin MR, et al. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab 2003; 88 (1): 141–7CrossRefPubMed
40.
go back to reference Taylor AE, McCourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82 (7): 2248–56PubMed Taylor AE, McCourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82 (7): 2248–56PubMed
41.
go back to reference Arroyo A, Laughlin GA, Morales AJ, et al. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997; 82 (11): 3728–33PubMed Arroyo A, Laughlin GA, Morales AJ, et al. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997; 82 (11): 3728–33PubMed
42.
go back to reference Berga SL, Daniels TL, Giles DE. Women with functional hypothalamic amenorrhea but not other forms of anovulation display amplified cortisol concentrations. Fertil Steril 1997; 67 (6): 1024–30CrossRefPubMed Berga SL, Daniels TL, Giles DE. Women with functional hypothalamic amenorrhea but not other forms of anovulation display amplified cortisol concentrations. Fertil Steril 1997; 67 (6): 1024–30CrossRefPubMed
43.
go back to reference Blank SK, McCartney CR, Helm KD, et al. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 2007; 25 (5): 352–9CrossRefPubMed Blank SK, McCartney CR, Helm KD, et al. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 2007; 25 (5): 352–9CrossRefPubMed
44.
go back to reference Yoo RY, Dewan A, Basu R, et al. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 2006; 85 (4): 1049–56CrossRefPubMed Yoo RY, Dewan A, Basu R, et al. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 2006; 85 (4): 1049–56CrossRefPubMed
45.
go back to reference Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006; 12 (4): 351–61CrossRefPubMed Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006; 12 (4): 351–61CrossRefPubMed
46.
go back to reference Williams NI. Lessons from experimental disruptions of the menstrual cycle in humans and monkeys. Med Sci Sports Exerc 2003; 35 (9): 1564–72CrossRefPubMed Williams NI. Lessons from experimental disruptions of the menstrual cycle in humans and monkeys. Med Sci Sports Exerc 2003; 35 (9): 1564–72CrossRefPubMed
47.
go back to reference Bullen BA, Skrinar GS, Beitins IZ, et al. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 1985; 312 (21): 1349–53CrossRefPubMed Bullen BA, Skrinar GS, Beitins IZ, et al. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 1985; 312 (21): 1349–53CrossRefPubMed
48.
go back to reference Myerson M, Gutin B, Warren MP, et al. Resting metabolic rate and energy balance in amenorrheic and eumenorrheic runners. Med Sci Sports Exerc 1991; 23 (1): 15–22CrossRefPubMed Myerson M, Gutin B, Warren MP, et al. Resting metabolic rate and energy balance in amenorrheic and eumenorrheic runners. Med Sci Sports Exerc 1991; 23 (1): 15–22CrossRefPubMed
49.
go back to reference Lebenstedt M, Platte P, Pirke KM. Reduced resting metabolic rate in athletes with menstrual disorders. Med Sci Sports Exerc 1999; 31 (9): 1250–6CrossRefPubMed Lebenstedt M, Platte P, Pirke KM. Reduced resting metabolic rate in athletes with menstrual disorders. Med Sci Sports Exerc 1999; 31 (9): 1250–6CrossRefPubMed
50.
go back to reference Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007; 92 (7): 2500–5CrossRefPubMed Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007; 92 (7): 2500–5CrossRefPubMed
51.
go back to reference Vrbikova J, et al. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome. Clin Chem Lab Med 2007; 45 (5): 639–44CrossRefPubMed Vrbikova J, et al. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome. Clin Chem Lab Med 2007; 45 (5): 639–44CrossRefPubMed
52.
go back to reference Legro RS, Gnatuk CL, Kunselman AR, et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005; 90 (6): 3236–42CrossRefPubMed Legro RS, Gnatuk CL, Kunselman AR, et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005; 90 (6): 3236–42CrossRefPubMed
53.
go back to reference Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111 (8): 607–13CrossRefPubMed Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111 (8): 607–13CrossRefPubMed
54.
go back to reference Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005; 106 (1): 131–7CrossRefPubMed Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005; 106 (1): 131–7CrossRefPubMed
55.
go back to reference Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002; 87 (5): 2013–7CrossRefPubMed Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002; 87 (5): 2013–7CrossRefPubMed
56.
go back to reference Barber TM, Wass JA, McCarthy MI, et al. Metabolic characteristics of women with polycystic ovaries and oligoamenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007; 66 (4): 513–7 Barber TM, Wass JA, McCarthy MI, et al. Metabolic characteristics of women with polycystic ovaries and oligoamenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007; 66 (4): 513–7
57.
go back to reference Carmina E, Chu MC, Longo RA, et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005; 90 (5): 2545–9CrossRefPubMed Carmina E, Chu MC, Longo RA, et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005; 90 (5): 2545–9CrossRefPubMed
58.
go back to reference Chang WY, Knochenhauer ES, Bartolucci AA, et al. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83 (6): 1717–23CrossRefPubMed Chang WY, Knochenhauer ES, Bartolucci AA, et al. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83 (6): 1717–23CrossRefPubMed
59.
go back to reference Dewailly D, Catteau-Jonard S, Reyss AC, et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 2006; 91 (10): 3922–7CrossRefPubMed Dewailly D, Catteau-Jonard S, Reyss AC, et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 2006; 91 (10): 3922–7CrossRefPubMed
60.
go back to reference Pehlivanov B, Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol 2007; 23 (10): 604–9CrossRefPubMed Pehlivanov B, Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol 2007; 23 (10): 604–9CrossRefPubMed
61.
go back to reference Shroff R, Syrop CH, Davis W, et al. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007; 88 (5): 1389–95CrossRefPubMed Shroff R, Syrop CH, Davis W, et al. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007; 88 (5): 1389–95CrossRefPubMed
62.
go back to reference Gosman GG, Katcher HI, Legro RS. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006; 12 (5): 585–601CrossRefPubMed Gosman GG, Katcher HI, Legro RS. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006; 12 (5): 585–601CrossRefPubMed
63.
64.
65.
go back to reference Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84 (4): 1470–4PubMed Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84 (4): 1470–4PubMed
66.
67.
go back to reference Stamets K, Taylor DS, Kunselman A, et al. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 2004; 81 (3): 630–7CrossRefPubMed Stamets K, Taylor DS, Kunselman A, et al. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 2004; 81 (3): 630–7CrossRefPubMed
68.
go back to reference Pasquali R, Gambineri A. Role of changes in dietary habits in polycystic ovary syndrome. Reprod Biomed Online 2004; 8 (4): 431–9CrossRefPubMed Pasquali R, Gambineri A. Role of changes in dietary habits in polycystic ovary syndrome. Reprod Biomed Online 2004; 8 (4): 431–9CrossRefPubMed
69.
go back to reference Palomba S, Giallauria F, Falbo A, et al. Structured exercise training programme versus hypocaloric hyperproteic dietin obese polycystic ovary syndrome patients with anovulator infertility: a 24-week pilot study. Hum Reprod 2008; 23 (3): 642–50CrossRefPubMed Palomba S, Giallauria F, Falbo A, et al. Structured exercise training programme versus hypocaloric hyperproteic dietin obese polycystic ovary syndrome patients with anovulator infertility: a 24-week pilot study. Hum Reprod 2008; 23 (3): 642–50CrossRefPubMed
70.
go back to reference Vigorito C, Giallauria F, Palomba S, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92 (4): 1379–84CrossRefPubMed Vigorito C, Giallauria F, Palomba S, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92 (4): 1379–84CrossRefPubMed
71.
go back to reference Manni L, Cajander S, Lundeberg T, et al. Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries. J Neuroendocrinol 2005; 17 (12): 846–58PubMed Manni L, Cajander S, Lundeberg T, et al. Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries. J Neuroendocrinol 2005; 17 (12): 846–58PubMed
72.
go back to reference Miller KK, Lawson EA, Mathur V, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007; 92 (4): 1334–9CrossRefPubMed Miller KK, Lawson EA, Mathur V, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007; 92 (4): 1334–9CrossRefPubMed
73.
go back to reference Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998; 83 (1): 25–32PubMed Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998; 83 (1): 25–32PubMed
74.
go back to reference Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006; 20 (2): 193–205CrossRefPubMed Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006; 20 (2): 193–205CrossRefPubMed
75.
go back to reference Mueller A, Dittrich R, Cupisti S, et al. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. Exp Clin Endocrinol Diabetes 2006; 114 (4): 182–7CrossRefPubMed Mueller A, Dittrich R, Cupisti S, et al. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. Exp Clin Endocrinol Diabetes 2006; 114 (4): 182–7CrossRefPubMed
76.
go back to reference Cho LW, Kilpatrick ES, Jayagopal V, et al. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia. Clin Endocrinol (Oxf) 2007; 68 (3): 390–4 Cho LW, Kilpatrick ES, Jayagopal V, et al. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia. Clin Endocrinol (Oxf) 2007; 68 (3): 390–4
77.
go back to reference Hahn S, Kuehnel W, Tan S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med 2007; 45 (2): 202–7CrossRefPubMed Hahn S, Kuehnel W, Tan S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med 2007; 45 (2): 202–7CrossRefPubMed
78.
go back to reference Mathur RS, Moody LO, Landgrebe S, et al. Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil Steril 1981; 35 (1): 29–35CrossRefPubMed Mathur RS, Moody LO, Landgrebe S, et al. Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil Steril 1981; 35 (1): 29–35CrossRefPubMed
79.
Metadata
Title
Oligomenorrhoea in Exercising Women
A Polycystic Ovarian Syndrome Phenotype or Distinct Entity?
Authors
Susan Awdishu
Nancy I. Williams
Sheila E. Laredo
Mary Jane De Souza
Publication date
01-12-2009
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 12/2009
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.2165/11317910-000000000-00000

Other articles of this Issue 12/2009

Sports Medicine 12/2009 Go to the issue

Acknowledgments

Acknowledgement